Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: A case series

Journal of Medical Case Reports

Volumn 4, Issue , 2010, Pages

  Ferreira Hermosillo, Aldo ^a   Torres Duran, Patricia V ^a   Juarez Oropeza, Marco A ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METOPROLOL; SPIRULINA EXTRACT; TRIACYLGLYCEROL;

ABDOMINAL PAIN; ACCIDENTAL INJURY; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASTHENIA; BLOOD SAMPLING; CARBOHYDRATE DIET; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; DIET SUPPLEMENTATION; FATIGUE; FATTY LIVER; FEMALE; FLATULENCE; HERBAL MEDICINE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTHYROIDISM; LABORATORY TEST; LIPID ANALYSIS; LIPID DIET; LIVER PROTECTION; LOW CALORY DIET; LOW DRUG DOSE; MALE; METEORISM; NAUSEA; NONALCOHOLIC FATTY LIVER; OVARY CANCER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; SMOKING; SPIRULINA MAXIMA; TABLET FORMULATION; THYROID CANCER; THYROIDECTOMY; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; ULTRASOUND;

EID: 77950652673     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-4-103     Document Type: Article

References (15)

1. National Institute of Statistics, Geography and Information (INEGI). http://www.inegi.gob.mx
2. The natural history of non-alcoholic fatty liver disease: a clinical histopathology study. SA Harrison S Torgensn PH Hayashi, Am J Gastroenterol 2003 98 9 2042 2047 10.1111/j.1572-0241.2003.07659.x 14499785
3. Evaluation and management of non-alcoholic steatohepatitis. S Ramesh AJ Sanyal, J Hepatol 2005 42 2 S12 10.1016/j.jhep.2004.11.022 15777569
4. Pathogenesis and management issues for non-alcoholic fatty liver disease. M Duvnjak I Lerotic N Barsic V Tomasic L Virovic V Velagic, World J Gastroenterol 2007 13 34 4539 4550 17729403
5. Non-alcoholic fatty liver disease and mitochondrial dysfunction. Y Wei RS Rector JP Thyfault JA Ibdah, World J Gastroenterol 2008 14 2 193 199 10.3748/wjg.14.193 18186554 (Pubitemid 351314298)
6. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. K Begriche A Igoudjil D Pessayre B Fromenty, Mitochondrion 2006 6 1 28 10.1016/j.mito.2005.10.004 16406828
7. Noninvasive assessment of hepatic steatosis. SM Mazhar M Shiehmorteza CB Sirlin, Clin Gastroenterol Hepatol 2009 7 2 135 140 10.1016/j.cgh.2008.11.023 19118644
8. Liver histology according to the presence of metabolic syndrome in nonalcoholic fatty liver disease cases. HS Uslusoy SG Nak M Gülten Z Biyikli, World J Gastroenterol 2009 15 9 1093 1098 10.3748/wjg.15.1093 19266602
9. Treatment regimens for non-alcoholic fatty liver disease. Bo Lam ZM Younossi, Ann Hepatol 2009 8 Suppl 1 51 S59 19381125
10. Nutritional andtherapeutic potential of Spirulina. Z Khan P Bhadouria PS Bisen, Curr Pharm Biotechnol 2005 6 373 379 10.2174/138920105774370607 16248810
11. Arthrospira maxima prevents the acute fatty liver induced by the administration of simvastatin, ethanol and a hypercholesterolemic diet to mice. JL Blé-Castillo A Rodríguez-Hernndez R Miranda-Zamora MA Jurez-Oropeza JC Díaz-Zagoya, Life Sci 2002 70 22 2665 2673 10.1016/S0024-3205(02)01512-6 12269393
12. Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report. PV Torres-Durn A Ferreira-Hermosillo MA Jurez-Oropeza, Lipids Health Dis 2007 6 33 10.1186/1476-511X-6-33 18039384
13. A novel protein C-phycocyanin plays a crucial role in the hypocholesterolemic action of Spirulina platensis concentrate in rats. S Nagaoka K Shimizu H Kaneko F Shibayama K Morikawa Y Kanamaru A Otsuka T Hirashi T Kato, J Nutr 2005 135 10 2425 2430 16177207
14. Isolation of pancreatic lipase activity-inhibitory component of Spirulina platensis and it reduce postprandial triacylglycerolemia. H Li-Kun L Dong-Xia X Lan G Xiao-Jie K Yasumasa S Isao O Hiromichi, Yakugaku Zasshi 2006 126 1 43 49 10.1248/yakushi.126.43 16394649
15. Protective effect of Spirulina fusiformis on chemical-induced genotoxicity in mice. K Premkumar SK Abraham ST Santhiya A Ramesh, Fitoterapia 2004 75 1 24 31 10.1016/j.fitote.2003.07.008 14693216